ClinicalTrials.Veeva

Menu

The Significance of Funguria in Hospitalized Patients (FACES)

L

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Status

Completed

Conditions

Urinary Tract Infections

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT00787085
NIH-AI01831
10024-05

Details and patient eligibility

About

This investigation is a epidemiologic case-control study of the risk factors associated with nosocomial funguria (fungi in the urine).

Full description

A recent large multi-center national surveillance survey of almost 5000 nosocomial (hospital based) urine isolates from medical intensive care units demonstrated that fungi comprised nearly 40% of urine isolates. Little is known about distinguishing fungi that cause colonization from those causing infection.

The objective of this study is to define the epidemiology of nosocomial funguria and natural history of patients that develop funguria while hospitalized.

Patients who may have eligible for this study will be identified from microbiology laboratory specimens at the Harbor-UCLA Medical Center and Cedars-Sinai Medical Center.

Enrollment

919 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients hospitalized at least 12 hours of any age (< 1 day to > 100 years of age) AND a urine or blood culture positive for fungi, OR urine culture negative for fungi (control group)

Exclusion criteria

  • Patients already surveyed for funguria during current hospitalization and patients already being followed for recognized funguria

Trial design

919 participants in 2 patient groups

Case
Description:
Patients hospitalized with a urine or blood culture positive for fungi
Control
Description:
Patients hospitalized with a urine culture negative for fungi

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems